Publications
- Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study2020 | First Faculty of Medicine
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) - 20182018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Nové léčebné postupy u chronické lymfocytární leukemie +12017 | First Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) Czech Group for Chronic Lymphocytic Leukaemia, section of the Czech Society of Haematology, CzMA2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future2015 | First Faculty of Medicine
- New drugs for the treatment of chronic lymphocytic leukemia2015 | First Faculty of Medicine
- Idelalisib in the treatment of chronic lymphocytic leukaemia2015 | First Faculty of Medicine
- No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma2011 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
Loading network view...